Controlled Substances and Inventory: Issues for Maryland’s Dispensing Physicians

Controlled Substances and Inventory: Issues for Maryland's Dispensing Physicians

This module was Board-approved and DHMH Secretary-approved to meet the CME requirements for dispensing permits.

The practice of dispensing any medication faces a certain amount of control and regulation, but when that medication is considered a “Controlled Substance” by the DEA, the control and regulation is taken to a whole new level. This module focuses on the intricacies of controlled substance laws and regulations as well as other practice nuances that will benefit any clinic considering dispensing these medications.

CE: 1.25 AMA PRA Category 1 Credit™, 1.25 ACPE Contact Hours
Universal Activity Number (UAN): 0025-0000-16-055-H03-P
Expiration Date: 04/22/2019
Course Number: KE-CN#MD003
Target Audience: Physicians, Pharmacists, Dentists
Instructor: Joey Mattingly, PharmD, MBA, Assistant Professor, University of Maryland School of Pharmacy

Other modules in this series include:

Learning Objectives (Physicians):
At the end of this course, the physician participant should be able to:

  1. Navigate online resources to find specific laws and regulations regarding controlled substances;
  2. Differentiate between the schedule classes of controlled substances as defined by the Controlled Substances Act (CSA) and match the dispensing, security, recordkeeping and DEA forms requirements for each; and
  3. Utilize best practices for inventory and maintaining records for inspection.

Your Instructor

Joey Mattingly, PharmD, MBA
Assistant Professor
University of Maryland School of Pharmacy

View Bio

Disclosures
Planners: The planners for this activity have reported no relevant relationships to disclose.
Presenters:
Controlled Substances and Inventory: Issues for Maryland's Dispensing Physicians
Joey Mattingly, PharmD, has reported no relevant relationships to disclose.

Technology Requirements

To access the course materials, you must use a computer with an internet connection and an online browser that supports the Adobe® Flash® Player version 10.  Mozilla® Firefox, Windows Internet Explorer 9 or higher, or Apple® Safari® for desktop are acceptable browsers.   

Successful Completion: Learners must complete all practice based activity components including the audiovisual presentations, post-test, and Activity Evaluation.  Participants must receive a score of at least 70% on the post-test in order to receive credit.  The post-test may be taken up to three (3) times. A link to the Activity Evaluation will be available on the confirmation once a learner has successfully completed the post-test. In order to receive CE credits, learners must complete the Activity Evaluation.  Statements of CE Credit will be available electronically via CPE Monitor within sixty (60) days of completion of the activity.

Conflict of Interest Disclosure: In accordance with the University of Maryland School of Pharmacy Policy on Conflicts of Interest, faculty certify that they had no potential conflicts of interest while developing the materials for this program.

Disclosure and Transparency in CME/CPD:
It is MedChi’s policy to ensure the independence, transparency, balance, objectivity, scientific rigor and integrity, as well as validation of content for all CME/CPD activities we accredit. To that end, faculty must disclose to the participants any relationships with companies identified as meeting the ACCME definition of a commercial interest. In the process of the disclosure process, all faculty and planners have disclosed the presences or absence of such relationships to MedChi. MedChi has identified, evaluated and where appropriate, attempted to resolve any potential conflicts of interest. This is done through the use of content validation, the use of evidence-based data, and multi-disciplinary peer review. The information provided as disclosure to the learner, is to inform the learner and aide in judgment, not to imply that disclosed relationships will have a negative effect on a presentation.

Accreditation Statement:
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of  MedChi, The Maryland State Medical Society, and The University of Maryland School of Pharmacy. MedChi is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statements:
Controlled Substances and Inventory: Issues for Maryland's Dispensing Physicians
MedChi designates this live educational activity for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Dispensing:
This module was Board-approved and DHMH Secretary-approved to meet the CME requirements for dispensing permits.

CME Credit: In order to receive CME credit for participation in these modules the learner is required to complete a post-test and achieve a score of 70% or higher for each module

Use of Trade Names:  The trade names of the drugs and delivery systems in this module are for the purpose of product identification only. The developers of this activity do not intend to imply endorsement for any commercial products discussed.

Resource Disclosure: Resources are provided for the educational benefit of our learners.  These materials are not for distribution.

Privacy and Confidentiality: The Center for Innovative Pharmacy Solutions (CIPS) is committed to protect the privacy of our learners; CIPS complies with federal regulations regarding privacy and confidentiality.  Email addresses may be used periodically to update learners on course offerings and new learning resources.  Certain personal information will be provided to the professional certifying entity in order to issue Certificates of Credit.  No personal information will be sold to third parties.  Your Activity Evaluation responses will be analyzed in aggregate. 

Copyright: All information and materials provided are the property of and have been prepared by the University of Maryland Baltimore or have been granted permission for use by the copyright owner.  No portion of this module may be reproduced or transmitted without written permission from CIPS.  All rights reserved. 

The University of Maryland School of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.



 

Refund Policy
  • A refund, less a $50 administration fee, will be made if cancellations are requested within 15 days. Other restrictions may apply.
  • Refund requests must be submitted in writing to cips@rx.umaryland.edu.
  • Refunds are not available in the following circumstances:
    • A learner has logged into a course or series;
    • Has launched course materials;
    • Course materials have been shipped; or
    • Request is made after 15 days of the ordering date.
  • Course registrations are non-transferrable.

Questions?  Review the Frequently Asked Questions page.  Can't find what you are looking for?  Contact Customer Service at cips@rx.umaryland.edu or 410-706-3381.